Medicare’s rebate authority comes from the Inflation Reduction Act, which also empowers the federal government to negotiate drug prices.
Author: Ken Alltucker, USA TODAY
Here’s why Medicaid coverage and free COVID tests, treatments will soon change
About 15 million may lose health insurance in May when the COVID emergency ends. Meanwhile, free vaccines and treatments will end by summer.
Medicare caps insulin costs at $35 a month. Can Biden get that price for all Americans?
In the State of the Union, Biden called to extend a monthly price cap of $35 on life-saving insulin for all Americans, not just those on Medicare.
Arthritis drug Humira’s two-decade reign ends as Amgen launches competing biosimilar
The price of Amgen’s rheumatoid arthritis drug called Amjevita is up to 55% less than the widely-prescribed Humira.
Why drugmakers have raised prices on nearly 1,000 drugs so far this year
Pharma companies raise prices on nearly 1,000 drugs as the Inflation Reduction Act phases in new federal restrictions in coming years. What to know.
‘This is alarming’: Childhood vaccination rates drop as measles and polio outbreaks emerge
Rising rates of of nonvaccinated children raises the risk for diseases to reemerge as vaccination rates slip, experts sya.
Medicare launches plan to negotiate prices for the costliest drugs. Here’s what to know.
As part of the Inflation Reduction Act, Medicare will negotiate drug prices, limit annual price hikes and cap insulin costs paid by older Americans.
FDA approves new drug lecanemab that appears to slow early, mild Alzheimer’s
Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease.
Half of ambulance rides yield surprise medical bills. What’s being done to protect people?
No Surprises Act protects consumers from costly surprise bills during emergency medical care, but not from ambulance bills.
‘Eat what you kill’: How a fentanyl drugmaker bribed doctors, harmed patients and collected millions
Documents reveal details about the culture of greed, power and sales at fentanyl drugmaker Insys, whose executives were jailed amid the opioid crisis.